Hu Yilan, Zhang Weihang, Ali Shah Rukh, Takeda Koji, Vahl Torsten Peter, Zhu Donghui, Hong Yi, Cheng Ke
Department of Biomedical Engineering, Columbia University, New York, NY 10032, USA.
Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
J Mol Cell Cardiol. 2025 Feb;199:12-32. doi: 10.1016/j.yjmcc.2024.11.005. Epub 2024 Nov 26.
Extracellular vesicles (EVs) are cell-secreted heterogeneous vesicles that play crucial roles in intercellular communication and disease pathogenesis. Due to their non-tumorigenicity, low immunogenicity, and therapeutic potential, EVs are increasingly used in cardiac repair as cell-free therapy. There exist multiple steps for the design of EV therapies, and each step offers many choices to tune EV properties. Factors such as EV source, cargo, loading methods, routes of administration, surface modification, and biomaterials are comprehensively considered to achieve specific goals. PubMed and Google Scholar were searched in this review, 89 articles related to EV-based cardiac therapy over the past five years (2019 Jan - 2023 Dec) were included, and their key steps in designing EV therapies were counted and analyzed. We aim to provide a comprehensive overview that can serve as a reference guide for researchers to design EV-based cardiac therapies.
细胞外囊泡(EVs)是细胞分泌的异质性囊泡,在细胞间通讯和疾病发病机制中发挥着关键作用。由于其无致瘤性、低免疫原性和治疗潜力,EVs作为无细胞疗法越来越多地用于心脏修复。EV疗法的设计存在多个步骤,每个步骤都提供了许多调节EV特性的选择。为实现特定目标,需综合考虑EV来源、货物、加载方法、给药途径、表面修饰和生物材料等因素。本综述检索了PubMed和谷歌学术,纳入了过去五年(2019年1月至2023年12月)89篇与基于EV的心脏治疗相关的文章,并对其设计EV疗法的关键步骤进行了统计和分析。我们旨在提供一个全面的概述,可为研究人员设计基于EV的心脏疗法提供参考指南。